Cargando…
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model
BACKGROUND: Proveblue®, a methylene blue dye that complies with European Pharmacopoeia and contains limited organic impurities and heavy metals of recognized toxicity, showed in vitro synergy against Plasmodium falciparum when combined with atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-Co...
Autores principales: | Dormoi, Jérome, Briolant, Sébastien, Desgrouas, Camille, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637457/ https://www.ncbi.nlm.nih.gov/pubmed/23587099 http://dx.doi.org/10.1186/1475-2875-12-127 |
Ejemplares similares
-
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
por: Dormoi, Jérôme, et al.
Publicado: (2013) -
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model
por: Souraud, Jean-Baptiste, et al.
Publicado: (2012) -
Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model
por: Dormoi, Jérôme, et al.
Publicado: (2022) -
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010) -
In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
por: Dormoi, Jérome, et al.
Publicado: (2014)